PCRX

$36.420.05%0.02

After Hours: 36.420.00 0.00%

Pacira Biosciences Inc (PCRX)

Pacira Biosciences Inc Stock (PCRX) Forecast

The Pacira Biosciences Inc (PCRX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $36.32, representing a -0.28% decrease from the current price of $36.42. The highest analyst price target is $41.47, and the lowest is $31.17.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month PCRX Price Target

Average 46.30 (+27.13% Downside)

Is Pacira Biosciences Inc (PCRX) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	83.20	Sell
STOCH(9,6)	59.61	Neutral
STOCHRSI(14)	12.87	Buy
MACD(12,26)	1.91	Sell
ADX(14)	64.30	Buy
William %R	-26.67	Neutral
CCI(14)	2.38	Neutral

Buy: 2 · Sell: 2 · Neutral: 3Summary: Neutral

Moving Averages

Period	Simple	Exponential
MA10	36.40 Buy	36.23 Buy
MA20	36.37 Buy	35.00 Buy
MA50	29.96 Buy	31.50 Buy
MA100	27.48 Buy	28.75 Buy
MA200	25.17 Buy	26.69 Buy

Buy: 10 · Sell: 0 · Neutral: 0Summary: Buy

According to our latest analysis, PCRX could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 2 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on PCRX, as trading bullish markets is always a lot easier

RSI (Relative Strength Index): The RSI(14) value of 83.20 indicates that PCRX is overbought. This suggests that PCRX price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
STOCH (Stochastic Oscillator): The STOCH value of 59.61 indicates that PCRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 12.87 indicates that PCRX is oversold. This suggests that PCRX price is at or near the lowest level relative to its recent price history.
ADX (Average Directional Index): The ADX value of 64.30 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
CCI (Commodity Channel Index): A CCI(14) value of 2.38 indicates that PCRX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term PCRX price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Pacira Biosciences Inc financial reports and earnings history, Pacira Biosciences Inc (PCRX) stock could reach $12.54 by 2030, $24.54 by 2040 and $55.77 by 2050. See the projected annual prices until 2050 of the Pacira Biosciences Inc stock below:

Pacira Biosciences Inc (PCRX) is expected to reach an average price of $12.77 in 2035, with a high prediction of $19.53 and a low estimate of $2.99. This indicates an -64.93% change from the last recorded price of $36.42.
Pacira Biosciences Inc (PCRX) stock is projected to chart a bullish course in 2040, with an average price target of $23.43, representing an -35.66% change from its current level. The forecast ranges from a conservative $15.75 to a sky-high $24.54.
Our analysts predict Pacira Biosciences Inc (PCRX) to change +13.29% by 2045, soaring from $28.30 to an average price of $41.26, potentially reaching $40.30. While $28.30 is the low estimate, the potential upside is significant.
Pacira Biosciences Inc (PCRX) stock is expected to climb by 2050, reaching an average of $51.07, a +40.22% change from its current level. However, a wide range of estimates exists, with high and low targets of $55.77 and $28.63, respectively, highlighting the market's uncertainty.

Pacira Biosciences Inc Stock (PCRX) Year by Year Forecast

Pacira Biosciences Inc Stock (PCRX) Price Forecast for 2026

The predicted value for Pacira Biosciences Inc (PCRX) in 2026 is set at an average of $27.18. Estimates vary from a peak of $41.47 to a trough of $18.80, indicating an -25.37% surge from the present price of $36.42.

Month	Average	Low	High	Change from today's price
December, 2026	$41.22	$31.17	$41.47	+13.17%

Pacira Biosciences Inc Stock (PCRX) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Pacira Biosciences Inc (PCRX) is $41.13, with a high forecast of $62.17 and a low forecast of $28.27. This indicates an +12.93% increase from the last price of $36.42.

Month	Average	Low	High	Change from today's price
January, 2027	$43.09	$38.61	$46.30	+18.31%
February, 2027	$43.45	$39.16	$45.17	+19.30%
March, 2027	$50.89	$40.23	$52.88	+39.72%
April, 2027	$57.88	$49.17	$57.91	+58.91%
May, 2027	$43.10	$42.29	$62.17	+18.35%
June, 2027	$43.46	$38.88	$44.89	+19.34%
July, 2027	$37.74	$30.43	$45.95	+3.64%
August, 2027	$35.62	$31.09	$39.72	-2.19%
September, 2027	$38.80	$35.50	$39.72	+6.54%
October, 2027	$36.39	$31.07	$38.90	-0.07%
November, 2027	$32.37	$32.25	$38.84	-11.12%
December, 2027	$30.73	$28.27	$36.19	-15.62%

Pacira Biosciences Inc Stock (PCRX) Price Forecast for 2028

In 2028, Pacira Biosciences Inc (PCRX) is projected to reach an average price of $20.91, with a high projection of $34.22 and a low estimate of $14.83. This indicates an -42.58% fall from the last price of $36.42.

Month	Average	Low	High	Change from today's price
January, 2028	$28.25	$26.95	$34.22	-22.44%
February, 2028	$19.71	$18.76	$29.33	-45.89%
March, 2028	$20.60	$16.55	$20.85	-43.44%
April, 2028	$23.20	$19.55	$24.40	-36.30%
May, 2028	$20.92	$19.85	$25.88	-42.57%
June, 2028	$23.98	$19.08	$24.61	-34.16%
July, 2028	$22.49	$21.46	$30.20	-38.24%
August, 2028	$17.90	$17.75	$24.31	-50.86%
September, 2028	$19.75	$17.25	$23.46	-45.78%
October, 2028	$21.46	$16.06	$22.14	-41.07%
November, 2028	$17.38	$17.04	$21.61	-52.27%
December, 2028	$15.33	$14.83	$18.66	-57.89%

Pacira Biosciences Inc Stock (PCRX) Price Forecast for 2029

The 2029 price forecast for Pacira Biosciences Inc Stock (PCRX) is $10.42 on average, with a high prediction of $18.59 and a low estimate of $2.74. This represents an -71.38% decrease from the previous price of $36.42.

Month	Average	Low	High	Change from today's price
January, 2029	$9.88	$8.90	$15.53	-72.87%
February, 2029	$10.30	$9.51	$13.65	-71.71%
March, 2029	$10.57	$8.39	$11.63	-70.97%
April, 2029	$14.86	$9.63	$18.59	-59.19%
May, 2029	$13.08	$12.88	$16.73	-64.08%
June, 2029	$12.56	$10.14	$14.25	-65.51%
July, 2029	$12.19	$10.78	$14.38	-66.53%
August, 2029	$9.40	$8.40	$12.46	-74.19%
September, 2029	$13.99	$8.53	$14.84	-61.59%
October, 2029	$11.95	$10.46	$14.89	-67.20%
November, 2029	$2.77	$2.74	$12.93	-92.40%
December, 2029	$3.54	$2.94	$7.50	-90.29%

Pacira Biosciences Inc Stock (PCRX) Price Forecast for 2030

Pacira Biosciences Inc Stock (PCRX) is expected to reach an average price of $5.88 in 2030, with a high forecast of $12.54 and a low forecast of $0.013. This signifies an -83.84% decrease from the last price of $36.42.

Month	Average	Low	High	Change from today's price
January, 2030	$3.26	$2.45	$2.31	-91.04%
February, 2030	$0.2411	$1.55	$1.38	-99.34%
March, 2030	$0.4272	$0.0272	$1.50	-98.83%
April, 2030	$0.8636	$0.013	$2.22	-97.63%
May, 2030	$3.70	$0.3888	$4.42	-89.83%
June, 2030	$6.52	$2.30	$6.83	-82.11%
July, 2030	$9.44	$6.02	$11.80	-74.07%
August, 2030	$8.52	$6.18	$11.00	-76.60%
September, 2030	$9.16	$6.27	$12.05	-74.85%
October, 2030	$9.73	$7.61	$12.54	-73.28%
November, 2030	$10.68	$7.87	$12.13	-70.67%
December, 2030	$8.06	$7.66	$11.04	-77.87%

Similar to PCRX